Volume 599 Issue 7885, 18 November 2021
Article | 21 September 2021
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
Optimization of monoclonal antibodies against SARS-CoV-2 for enhanced Fc-effector function increase their effectiveness for prevention and treatment of COVID-19 in multiple animal models of SARS-CoV-2 infection.
Rachel Yamin, Andrew T. Jones, Stylianos Bournazos